Medical Supervised Weight Loss with Tirzepatide

Tirzepatide, (an active ingredient of the brand name Mounjaro) is an anti-diabetic medication used in treating type two diabetes and off-label use for obesity by inducing weight loss and lowering postprandial glucose concentration. Tirzepatide subcutaneous injection is used once a week for the treatment of obesity.

Tirzepatide treats diabetes and induces weight loss by the following mechanism:

• It delays gastric emptying time
• It decreases the need for food intake
• It lowers fasting and postprandial (after meal) glucose concentration

Tirzepatide is contraindicated in patients with:

• Decreased kidney function
• Diabetes retinopathy
• Pancreatitis
• Hypersensitivity to the drug
• Medullary thyroid cancer
• A disease of the gallbladder 

The Package Starting at $500 per vial Includes: 

• Personalized Weight Loss Plan and Follow-Up Visits
• Medication and shipping
• Messaging Support
• Metabolic & Nutritional Health Plan
• Functional Lab Assessments
• Discount on Professional Grade Supplements

If you are struggling with obesity, we invite you to schedule a consultation with our team to learn more about our approach to treatment and how we can help you achieve your weight loss goals. We look forward to partnering with you on your journey to better health.